Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives

AuthorXiang-Long Wuen
AuthorLiu Liuen
AuthorQing-Chuan Wangen
AuthorHai-Fang Wangen
AuthorXiang-Rong Zhaoen
AuthorXu-Bin Linen
AuthorWen-Jun Lven
AuthorYin-Bo Niuen
AuthorTing-Li Luen
AuthorQi-Bing Meien
Issued Date2020-07-31en
AbstractTo explore novel antitumor agents with high efficiency and low toxicity, riluzole alkyl derivatives (4a-4i) were synthesized. Their anti-proliferative activities against HeLa, HepG2, SP2/0, and MCF-7 cancer cell lines were assessed by the CCK-8 assay and compared with human normal liver (LO2) cells. Most of them showed potent cytotoxic effects against four human tumor cell lines and low toxic to LO2 cells. In particular, 2-(N-ethylamine)-6-trifluoromethoxy- benzothiazole (4a) showed a IC50 value of 7.76 μmol/L in HeLa cells and was found to be nontoxic to LO2 cells up to 65 μmol/L. Furthermore, flow cytometry indicated that 4a could induce remarkable early apoptosis and G2/M cell cycle arrest in HeLa cells. It also impaired the migration ability of HeLa cells in wound healing assays. Western blot results demonstrated that 4a suppressed Bcl-2 protein expression but increased the level of Bax in HeLa cells, and elevated the Bax/Bcl-2 expression ratio. These new findings suggest that 4a exhibited beneficially anti-cervical cancer effect on HeLa cells by inducing HeLa cell apoptosis.en
DOIhttps://doi.org/10.22037/ijpr.2020.1101149en
KeywordRiluzoleen
KeywordBenzothiazole derivativesen
KeywordAntitumour activityen
KeywordSynthesisen
KeywordMechanismen
PublisherBrieflandsen
TitleAntitumor Activity and Mechanism Study of Riluzole and Its Derivativesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-19-217.pdf
Size:
1010.08 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF